Medimmune

Medimmune company information, Employees & Contact Information

Explore related pages

Related company profiles:

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres, with additional sites in Cambridge, UK and South San Francisco, CA. For more information, please visit www.medimmune.com

Company Details

Employees
924
Founded
-
Address
1 Medimmune Way, Gaithersburg,maryland 20878,united States
Phone
301-398-0000
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Gaithersburg, Maryland
Looking for a particular Medimmune employee's phone or email?

Medimmune Questions

News

AstraZeneca to strengthen presence in California with new South San Francisco location - AstraZeneca US

AstraZeneca to strengthen presence in California with new South San Francisco location AstraZeneca US

Sponsors | Cancer immunotherapy - Nature

Sponsors | Cancer immunotherapy Nature

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status - Wiley

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status Wiley

AstraZeneca retires Medimmune name amid sales turnaround - BioPharma Dive

AstraZeneca retires Medimmune name amid sales turnaround BioPharma Dive

Biologics: The Next-Generation Therapeutics for Analgesia? - Medscape

Biologics: The Next-Generation Therapeutics for Analgesia? Medscape

A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity - Science | AAAS

A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity Science | AAAS

Rescue of influenza B virus from eight plasmids - PNAS

Rescue of influenza B virus from eight plasmids PNAS

Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays - Wiley Online Library

Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays Wiley Online Library

AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer - AstraZeneca US

AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer AstraZeneca US

T follicular helper–like cells contribute to skin fibrosis - Science | AAAS

T follicular helper–like cells contribute to skin fibrosis Science | AAAS

A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions - PNAS

A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions PNAS

Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma - Wiley

Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma Wiley

AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress - AstraZeneca US

AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress AstraZeneca US

Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system - PNAS

Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system PNAS

Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug-Resistant Enterobacteriaceae - Wiley Online Library

Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug-Resistant Enterobacteriaceae Wiley Online Library

Book Review: ADME and Translational Pharmacokinetics/Pharmacodynamics of Therapeutic Proteins - Wiley

Book Review: ADME and Translational Pharmacokinetics/Pharmacodynamics of Therapeutic Proteins Wiley

A Diene-Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels–Alder Reaction with Maleimide or Proximity-Based Dimerization - Wiley Online Library

A Diene-Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels–Alder Reaction with Maleimide or Proximity-Based Dimerization Wiley Online Library

Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity - Wiley Online Library

Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity Wiley Online Library

Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability - Wiley Online Library

Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability Wiley Online Library

Polysome profiling of mAb producing CHO cell lines links translational control of cell proliferation and recombinant mRNA loading onto ribosomes with global and recombinant protein synthesis - Wiley Online Library

Polysome profiling of mAb producing CHO cell lines links translational control of cell proliferation and recombinant mRNA loading onto ribosomes with global and recombinant protein synthesis Wiley Online Library

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action - Taylor & Francis Online

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action Taylor & Francis Online

Cancer stem cell plasticity and tumor hierarchy - Baishideng Publishing Group

Cancer stem cell plasticity and tumor hierarchy Baishideng Publishing Group

A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease - Nature

A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease Nature

N-terminal or signal peptide sequence engineering prevents truncation of human monoclonal antibody light chains - Wiley Online Library

N-terminal or signal peptide sequence engineering prevents truncation of human monoclonal antibody light chains Wiley Online Library

Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development - Wiley Online Library

Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development Wiley Online Library

Are mast cells instrumental for fibrotic diseases? - Frontiers

Are mast cells instrumental for fibrotic diseases? Frontiers

The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory - Frontiers

The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory Frontiers

Full article: Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding - Taylor & Francis Online

Full article: Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding Taylor & Francis Online

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier - Frontiers

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier Frontiers

Medimmune, Biologics Manufacturing Facility - Pharmaceutical Technology

Medimmune, Biologics Manufacturing Facility Pharmaceutical Technology

Human NLRP3 inflammasome senses multiple types of bacterial RNAs - PNAS

Human NLRP3 inflammasome senses multiple types of bacterial RNAs PNAS

FASENRA (BENRALIZUMAB) RECEIVES US FDA APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA - MultiVu

FASENRA (BENRALIZUMAB) RECEIVES US FDA APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA MultiVu

AstraZeneca’s IMFINZI™ (durvalumab) Receives US FDA Accelerated Approval - MultiVu

AstraZeneca’s IMFINZI™ (durvalumab) Receives US FDA Accelerated Approval MultiVu

Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils - Frontiers

Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils Frontiers

Safety/Toxicity Issues in Drug Discovery - Genetic Engineering and Biotechnology News

Safety/Toxicity Issues in Drug Discovery Genetic Engineering and Biotechnology News

Cross-functional teams: Models of success - PharmaVoice

Cross-functional teams: Models of success PharmaVoice

Investigation of Foreign-Particle Contamination: Practical Application of FT-IR, Raman, and SEM-EDS Technologies - BioProcess International

Investigation of Foreign-Particle Contamination: Practical Application of FT-IR, Raman, and SEM-EDS Technologies BioProcess International

Position Paper: Are We Abandoning IQ and OQ? - PharmTech

Position Paper: Are We Abandoning IQ and OQ? PharmTech

Top Medimmune Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant